Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Arixtra (Fondaparinux Sodium) Injection, Fonda BV NDA 21-345/S2 6/17/03 7/8/03 7/8/03 Arixtra (Fondaparinux Sodium) Injection, 2.5 mg, Fonda BV NDA 21-345/S1 12/4/02 12/9/02 12/6/02 Arixtra (Fondaparinux Sodium) Injection, 2.5 mg, Fonda BV NDA 21-345 Lovenox (fondaparinux sodium, injection), Aventis Pharmaceuticals ARIXTRA (fondaparinux sodium) Injection, Fonda B.V. | Arixtra (fondaparinux sodium) Injection, GlaxoSmithKline, New or Modified Indication | Arixtra (fondaparinux sodium) Subcutaneous Injection, GlaxoSmithKline, Labeling Revision | Arixtra (fondaparinux sodium) Subcutaneous Injection, GlaxoSmithKline, Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com